Scoliosis

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Prognosis
• Symptoms
• Diagnosis
• Treatment
• Managing Scoliosis
• Braces
• Surgery
• Treatment for Adult Scolios...
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Diagnosing Scoliosis Scoliosis is diagnosed typically in children 10 - 15 years of age. However, only about 1% of cases actually require treatment. There is a large female preponderance for larger curves that do require treatment. - 0 Comments

Insomnia

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes of Short-Term or Tra...
• Causes of Chronic Insomnia...
• Risk Factors
• Prognosis
• Diagnosis
• Treatment
• Medications
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Sedative Hypnotic Drug Warnings In March 2007, the FDA ordered stronger warning labels on sedative hypnotic drugs. These medications include benzodiazepine and non-benzodiazepine drugs, such as zolpidem (Ambien), eszopiclone (Lunesta), ramelteon (Rozerem), and triazolam (Halcion). The FDA warned that these drugs may be associated with:

• Severe allergic reactions (anaphylaxis) and severe facial swelling (angioedema), which can occur even the first time a drug is taken
• Complex sleep-related behaviors, such as sleep driving, making phone calls, and preparing and eating food while asleep

Patients who take sleeping pills should be sure to follow the directions. - 4 Comments

Diabetes - type 2

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Screening Tests
• Treatment
• Lifestyle Changes
• Medications
• Long-Term Complications
• Emergency Complications
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approvals

• Sitagliptin (Januvia), the first in a new class of diabetes drugs called DPP-4 inhibitors, was approved in 2006.
• Janumet, a 2-in-1 pill that contains both sitagliptin and metformin, was approved in 2007.
• These drugs are taken by mouth and may be more convenient for patients than exenatide (Byetta), a similar drug. DPP-4 inhibitors do not cause weight gain and may pose a lower risk for hypoglycemia than some other diabetes drugs.

Drug Safety Alert Rosiglitazone (Avandia) may significantly increase the risk for heart attack, indicates a review published in the Journal of the American Medical Association. In 2007, a panel of experts from the Food and Drug Administration (FDA) agreed the drug increases the risk of heart attacks -- but concluded it should remain on the market. - 4 Comments

Foot pain

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Treatment: Corns and Callus...
• Treatment: Bunions
• Treatment: Hammertoes
• Treatment: Ingrown Toenails...
• Treatment: Forefoot Pain...
• Treatment: Heel Pain
• Treatment: Flat Feet
• Treatment: Abnormally High ...
• Treatment: Tarsal Tunnel Sy...
• Treatment: Foot Injury
• Prevention
• Shoes
• Insoles and Orthotics
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Treatment for Ingrown Toenail:

• Orthonyxia, a surgical technique that implants a small metal brace into the top of the nail, was as effective as traditional surgical techniques for preventing ingrown toenail from recurring, according to one study.
• A nonsurgical method for treating ingrown toenail with chemicals uses either sodium hydroxide or phenol, but one study shows that sodium hydroxide procedures have a better outcome and faster recovery than phenol procedures.

Treatment for Forefoot Pain:

• Ultrasound-guided injection of alcohol might provide relief from Morton's neuroma, according to one study. Symptoms improved in 94% of patients who had the treatment, a success rate comparable to that of surgery.

Treatment for Heel Pain:

• NSAIDs reduce pain and disability in people with plantar fasciitis when used with other techniques, such as night splints and stretching.
• Studies show that extracorporeal shockwave therapy provides a very small reduction in heel pain without side effects. It may be a good option for patients who haven't responded well to conservative treatment.

Work-related Foot Problems:

• An estimated 120,000 job-related foot injuries occur every year, about a third of them involving the toes. - 0 Comments
  Read More ›

Stress

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• The Body's Response
• Complications
• Conditions with Similar Sym...
• Treatment
• Risk Factors
• Lifestyle Changes
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights

• Some people are pre-programmed for a heightened response to stress by conditions in the womb. Pregnant women under stress who eat a diet high in protein and low in carbohydrates have babies with higher cortisol levels. Later on, these levels increase in response to stress.
• The impact of stress on the heart and circulation system is becoming more clear. - 0 Comments
  Read More ›

Urinary incontinence

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Stress Incontinence
• Urge Incontinence
• Overflow Incontinence
• Functional Incontinence
• Risk Factors
• Diagnosis
• Prognosis
• Treatment
• Lifestyle Changes
• Other Treatments
• Behavioral Treatments
• Medications
• Surgery
• Other Procedures
• Catheters and Collection De...
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Sling Procedure Versus Burch Colposuspension The sling procedure is better than Burch colposuspension in treating stress incontinence but may cause more post-operative urinary complications, according to results from an important 2007 New England Journal of Medicine study. In the first large-scale clinical trial to directly compare these two types of surgery, 47% of women who underwent the sling procedure had no urinary incontinence 2 years after surgery, compared with 38% of women who received the Burch procedure. However, 63% of women who had the sling procedure (and 47% of women who underwent the Burch procedure) experienced urinary tract infections following surgery. - 0 Comments

Glaucoma

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Outlook
• Risk Factors
• Diagnosis
• Treatment
• Medications
• Surgery
• Lifestyle Changes
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approval Bimatoprost (Lumigan) has been approved as a first-line treatment for open-angle glaucoma. Glaucoma Cases Increasing Worldwide About 60 million people worldwide will have glaucoma by 2010, and the number will increase to nearly 80 million by 2010, according to a recent study in the British Journal of Ophthalmology. Weightlifting May Increase Glaucoma Risk Weightlifting can cause a temporary increase in intraocular eye pressure (IOP), and holding your breath while lifting weights further increases IOP, suggests a 2006 study in the Archives of Ophthalmology. - 0 Comments

Uterine fibroids and hysterectomy

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Risk Factors
• Complications
• Diagnosis
• Lifestyle Changes
• Medications
• Surgery
• Other Procedures
• Hysterectomy
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Uterine Artery Embolization Versus Standard Surgery Many women with fibroids are considering a procedure called uterine artery embolization (UAE) as an alternative to standard surgery such as hysterectomy or myomectomy. A study published in 2007 in the New England Journal of Medicine compared these treatment approaches. The study suggested that UAE results in shorter hospital stay and faster recovery time, but a small percentage of women may later need repeat embolization or a hysterectomy. - 0 Comments

Diabetes - type 1

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Life-Threatening Complicati...
• Diagnosis
• Dietary Goals and Exercise...
• Treatment
• Monitoring Tests
• Long-Term Complications
• Transplantation Procedures...
• Prevention
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights New Continuous Glucose Meter System In 2007, the FDA approved the STS-7 System, which monitors glucose levels every 5 minutes during a 7-day period. The STS-7 System, like other continuous glucose meter systems, is designed to be used in combination with traditional fingerstick tests and meters. It does not replace them. - 3 Comments